WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017174731) GLUCONO DELTA-LACTONE FOR TREATMENT OF VAGINAL FUNGAL INFECTIONS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2017/174731    International Application No.:    PCT/EP2017/058268
Publication Date: 12.10.2017 International Filing Date: 06.04.2017
IPC:
A61K 9/00 (2006.01), A61K 31/366 (2006.01), A61P 31/10 (2006.01)
Applicants: GEDEA BIOTECH AB [SE/SE]; Medicon Village Scheelevägen 2 223 81 Lund (SE)
Inventors: ELLERVIK, Ulf; (SE).
STERNER, Olov; (SE).
STREVENS, Helena; (SE).
MANNER, Sophie; (SE)
Agent: HØIBERG P/S; Adelgade 12 1304 Copenhagen K (DK)
Priority Data:
1650467-2 06.04.2016 SE
Title (EN) GLUCONO DELTA-LACTONE FOR TREATMENT OF VAGINAL FUNGAL INFECTIONS
(FR) GLUCONO DELTA-LACTONE POUR LE TRAITEMENT D'INFECTIONS FONGIQUES VAGINALES
Abstract: front page image
(EN)The present invention relates to a pharmaceutical formulation for vaginal administration, wherein the formulation comprises a pharmaceutical acceptable excipient and glucono δ-lactone,wherein the glucono δ-lactoneis present in an amount of 5 to 99 wt % of the formulation. The invention also relates to a pharmaceutical formulation according to the invention for use in the prevention or treatment of a urogenital fungal infection. Furthermore, the invention relates to glucono δ-lactone (formula (III)), for use in the in the prevention or treatment of a fungal infection.
(FR)La présente invention concerne une formulation pharmaceutique pour l'administration vaginale, la formulation comprenant un excipient pharmaceutiquement acceptable et une glucono δ-lactone, la glucono δ-lactone étant présente suivant une quantité représentant de 5 à 99 % en poids de la formulation. L'invention concerne également une formulation pharmaceutique selon l'invention destinée à être utilisée dans la prévention ou le traitement d'une infection fongique urogénitale. En outre, l'invention concerne la glucono δ-lactone (formule (III)), destinée à être utilisée dans la prévention ou le traitement d'une infection fongique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)